Ticker

No recent analyst price targets found for PSP.

Latest News for PSP

Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)

LILLE, France--(BUSINESS WIRE)-- #PSP--Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. “FDA IND clearance is a pivotal step in our PSP…

Business Wire • May 28, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for PSP.

No Senate trades found for PSP.

No House trades found for PSP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top